Search Results - "Hato, S. V."
-
1
The tumour microenvironment shapes dendritic cell plasticity in a human organotypic melanoma culture
Published in Nature communications (02-06-2020)“…The tumour microenvironment (TME) forms a major obstacle in effective cancer treatment and for clinical success of immunotherapy. Conventional co-cultures have…”
Get full text
Journal Article -
2
Inhibition of mRNA export and dimerization of interferon regulatory factor 3 by Theiler's virus leader protein
Published in Journal of general virology (01-01-2009)“…1 Université Catholique de Louvain, de Duve Institute, Brussels, Belgium 2 Department of Medical Microbiology, Radboud University Nijmegen Medical Centre,…”
Get full text
Journal Article Web Resource -
3
Expansion of a BDCA1+CD14+ Myeloid Cell Population in Melanoma Patients May Attenuate the Efficacy of Dendritic Cell Vaccines
Published in Cancer research (Chicago, Ill.) (01-08-2016)“…The tumor microenvironment is characterized by regulatory T cells, type II macrophages, myeloid-derived suppressor cells, and other immunosuppressive cells…”
Get full text
Journal Article -
4
Cisplatin inhibits frequency and suppressive activity of monocytic myeloid-derived suppressor cells in cancer patients
Published in Oncoimmunology (01-01-2021)“…Cancer immunotherapies have induced long-lasting responses in cancer patients including those with melanoma and head and neck squamous cell carcinoma (HNSCC)…”
Get full text
Journal Article -
5
Dendritic cell cross talk with innate and innate-like effector cells in antitumor immunity: implications for DC vaccination
Published in Critical reviews in immunology (2014)“…Dendritic cells (DCs) are key players in the induction of immune responses. Adoptive transfer of autologous mature DCs loaded with tumor-associated antigens is…”
Get full text
Journal Article